12.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
25.81%
13.46
|
10.70 | 15.43 | 16.44 | 14.77 |
Cost Of Revenue |
54.04%
1.944
|
1.262 | 1.561 | 1.509 | 1.326 |
Gross Profit |
22.03%
11.52
|
9.436 | 13.86 | 14.93 | 13.45 |
|
7.91%
79.16
|
73.35 | 59.86 | 58.52 | 45.06 |
Benefits Costs and Expenses |
8.49%
81.10
|
74.75 | 61.42 | 60.03 | 79.62 |
Costs And Expenses |
8.69%
81.10
|
74.61 | 61.42 | 60.03 | 46.39 |
Operating Income/Loss |
5.83%
-67.64
|
-63.92 | -46.00 | -43.59 | -31.62 |
Nonoperating Income/Loss |
27.21%
-0.173
|
-0.136 | 9.505 | -0.187 | -33.23 |
Income/Loss From Continuing Operations Before Tax |
5.60%
-67.64
|
-64.05 | -46.00 | -43.78 | -64.85 |
Income/Loss From Continuing Operations After Tax |
5.87%
-67.81
|
-64.05 | -36.49 | -43.78 | -64.85 |
|
5.87%
-67.81
|
-64.05 | -36.49 | -43.78 | -64.85 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.89%
172.59
|
169.40 | 166.99 | 165.82 | 132.02 |
Diluted Average Shares |
1.89%
172.59
|
169.40 | 166.99 | 165.82 | 132.02 |
Basic Earnings Per Share |
2.63%
-0.39
|
-0.38 | -0.22 | -0.26 | -0.49 |
Diluted Earnings Per Share |
2.63%
-0.39
|
-0.38 | -0.22 | -0.26 | -0.49 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):